Ezutromid

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameEzutromid
Drug Alias Name依珠曲米ezutromidum依珠卓米ezutromidVOX-C1100 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUtrophin activators
TargetsUtrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSummit Pharmaceuticals International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSummit Therapeutics
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksWikipedia